Telix’s $397M convertible bond offering; Scynexis records a $10M milestone

Plus, news about Windtree Therapeutics, MEI Pharma and ViiV:

Telix raises $397M in convertible bond offering: The radiopharma biotech plans to use the funds to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Danish biotech Gubra touts early weight loss data in hot amylin field

The amylin field is heating up ahead of Novo Nordisk’s much-anticipated CagriSema readout later this year. On Wednesday, Gubra said people … Sign up to

November 14, 2024

Study provides key insights into the communication process surrounding innovative surgical procedures

Patients are not given sufficient information about the novel status of a procedure, possible uncertainties or potential risks when deciding to go ahead with the

August 14, 2023

Successful First Half of 2024 with Strategic Progress and Solid Financial Figures – Biotech Investments

Xlife Sciences AG / Key word(s): Half Year Results/Interim Report 19-Sep-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR

September 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.